Stocktoria

Lyell Immunopharma, Inc. LYEL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-17

Lyell Immunopharma, Inc. institutional holders

InvestorSharesValue% of company
MILLENNIUM MANAGEMENT LLC367,473$5.2M1.73%
RENAISSANCE TECHNOLOGIES LLC130,190$1.8M0.61%
CITADEL ADVISORS LLC53,595$753,0100.25%
TWO SIGMA INVESTMENTS, LP52,927$743,6240.25%
Point72 Asset Management, L.P.26,080$366,4240.12%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.